<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A thorough assessment of vision with special attention to formal visual field testing is the cornerstone to decision making in idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>After the diagnosis of idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> has been established, vision should be thoroughly assessed </plain></SENT>
<SENT sid="2" pm="."><plain>If there is no <z:hpo ids='HP_0000572'>visual loss</z:hpo>, the patient can be followed carefully </plain></SENT>
<SENT sid="3" pm="."><plain>In patients with symptoms and only a few signs (eg, mild blind-spot enlargement), <z:chebi fb="0" ids="27690">acetazolamide</z:chebi>, 1 to 2 g, or another <z:chebi fb="40" ids="35498">diuretic</z:chebi> should be initiated </plain></SENT>
<SENT sid="4" pm="."><plain>In patients with <z:hpo ids='HP_0000529'>progressive visual loss</z:hpo> in whom maximal <z:chebi fb="40" ids="35498">diuretic</z:chebi> therapy fails and in those who on initial evaluation have significant recent <z:hpo ids='HP_0000572'>visual loss</z:hpo> that does not respond to maximal <z:chebi fb="40" ids="35498">diuretic</z:chebi> therapy, optic nerve sheath decompression or lumbar peritoneal shunting should be carried out </plain></SENT>
<SENT sid="5" pm="."><plain>With <z:hpo ids='HP_0000001'>all</z:hpo> treatments, <z:hpo ids='HP_0001824'>weight loss</z:hpo> should be encouraged </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients should be evaluated regularly with visual field testing </plain></SENT>
</text></document>